**Core Concept**
Tardive dyskinesia is a side effect of long-term use of antipsychotic medications, characterized by involuntary, repetitive movements of the face, trunk, and limbs. This condition is often resistant to treatment and requires specific pharmacological management.

**Why the Correct Answer is Right**
The treatment of tardive dyskinesia involves the use of medications that either reverse the condition or prevent its progression. **Valbenazine** is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, which reduces the release of dopamine into the synaptic cleft, thereby alleviating the symptoms of tardive dyskinesia. This mechanism is distinct from typical antipsychotics, which block dopamine receptors, further exacerbating the condition.

**Why Each Wrong Option is Incorrect**
**Option A:** **Haloperidol** is a typical antipsychotic that blocks dopamine receptors, which can worsen tardive dyskinesia.
**Option B:** **Clozapine** is an atypical antipsychotic that may have a lower risk of causing tardive dyskinesia, but it is not specifically indicated for its treatment.
**Option C:** **Benzhexol** is an anticholinergic medication used to treat extrapyramidal side effects, but it is not effective for tardive dyskinesia.

**Clinical Pearl / High-Yield Fact**
Be aware that the treatment of tardive dyskinesia often requires a multidisciplinary approach, including medication management, physical therapy, and behavioral interventions.

**Correct Answer:** C. Benzhexol is an anticholinergic medication used to treat extrapyramidal side effects, but it is not effective for tardive dyskinesia.